Literature DB >> 25418215

Micro-RNA 21Targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts.

Shulei Liu1, Wenqi Li1, Mingtong Xu2, Hui Huang1, Jingfeng Wang1, Xiaochao Chen3.   

Abstract

BACKGROUND: Micro-RNA 21 (miR-21) has been shown to contribute to cardiac fibrosis in many diseases. In this study we investigated the role of miR-21 in excessive production of collagen in diabetic cardiomyopathy.
METHODS: The proliferation rate of cardiac fibroblasts was analyzed by Western blot, Cell Counting Kit-8 kit (Dojindo Molecular Technologies, Kumamoto, Japan), and Cell-Light EdU Apollo 488 In Vitro Imaging Kit (RiboBio, Guangzhou, China). Real-time polymerase chain reaction and Western blotting were conducted to determine gene expression levels. A luciferase reporter assay was used to verify the interaction between miR-21 and the 3' untranslated region (3'UTR) of dual specific phosphatase 8 (DUSP8).
RESULTS: Our results show that high glucose promoted the proliferation and collagen synthesis of rat cardiac fibroblasts, which was accompanied by an increase of miR-21. Gain-of-function and loss-of-function assays confirmed that miR-21 mediated this effect, suggesting the crucial role of miR-21 in diabetic cardiomyopathy. Our study also identified a direct target of miR-21, DUSP8, which regulates cell proliferation and collagen synthesis in cardiac fibroblasts through p38 and c-Jun N-terminal kinase (JNK)/stress-activated kinase (SAPK) signalling. Our results show that miR-21 bound to the 3'UTR of DUSP8 post-transcriptionally repressed its expression. In addition, enforced expression of miR-21 activated the JNK/SAPK and p38 signalling pathways.
CONCLUSIONS: Our study shows that miR-21 promotes high glucose-induced cardiac fibrosis through the JNK/SAPK and p38 signalling pathways by suppressing DUSP8 expression.
Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25418215     DOI: 10.1016/j.cjca.2014.07.747

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  37 in total

Review 1.  LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives.

Authors:  Hui Tao; Zheng-Yu Song; Xuan-Sheng Ding; Jing-Jing Yang; Kai-Hu Shi; Jun Li
Journal:  Endocrine       Date:  2018-07-27       Impact factor: 3.633

Review 2.  Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.

Authors:  Rui Guo; Sreejayan Nair
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-24       Impact factor: 5.187

3.  Role of microRNAs in the pathogenesis of diabetic cardiomyopathy.

Authors:  Xinyu Liu; Shixue Liu
Journal:  Biomed Rep       Date:  2017-01-12

4.  Na/K-ATPase signaling regulates collagen synthesis through microRNA-29b-3p in cardiac fibroblasts.

Authors:  Christopher A Drummond; Michael C Hill; Huilin Shi; Xiaoming Fan; Jeffrey X Xie; Steven T Haller; David J Kennedy; Jiang Liu; Michael R Garrett; Zijian Xie; Christopher J Cooper; Joseph I Shapiro; Jiang Tian
Journal:  Physiol Genomics       Date:  2015-12-23       Impact factor: 3.107

Review 5.  Diabetic fibrosis.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-12-28       Impact factor: 5.187

Review 6.  MicroRNA-mediated control of myocardial infarction in diabetes.

Authors:  Daniel Pérez-Cremades; Jingshu Chen; Carmel Assa; Mark W Feinberg
Journal:  Trends Cardiovasc Med       Date:  2022-01-17       Impact factor: 8.049

7.  Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells.

Authors:  Lijun Zhang; Jie Zhang; Changgeng Xu; Xiangjun Zhou; Wei Wang; Renping Zheng; Wei Hu; Pin Wu
Journal:  Drug Des Devel Ther       Date:  2015-08-14       Impact factor: 4.162

Review 8.  Looking into a conceptual framework of ROS-miRNA-atrial fibrillation.

Authors:  Seahyoung Lee; Eunhyun Choi; Min-Ji Cha; Ki-Chul Hwang
Journal:  Int J Mol Sci       Date:  2014-11-26       Impact factor: 5.923

Review 9.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

Review 10.  The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy.

Authors:  Shudong Wang; Lijuan Ding; Honglei Ji; Zheng Xu; Quan Liu; Yang Zheng
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.